Download Free Pharmacotherapy Of Diabetes New Developments Book in PDF and EPUB Free Download. You can read online Pharmacotherapy Of Diabetes New Developments and write the review.

Diabetes is a huge and growing healthcare worry, especially in Western countries. The treatment of both types – 1 and 2 – of this disease has changed radically over the past few years. This work provides an overview of all the changes that will come to be implemented in clinical practice. Summarizing all aspects of treatment, this book delineates the large amount of research work that has been completed over the last few years into the relief of complications in diabetes and vascular medicine in general.
The current epidemic of diabetes, obesity and related disorders is a driving force in the development of new technologies. Technological advances offer great new opportunities for the treatment of these chronic diseases. This review presents an update of developments that promise to revolutionize the treatment of diabetes. It examines hospital and outpatient care, intensive insulin therapy, blood glucose monitoring and innovative steps towards the construction of an artificial pancreas. Providing a comprehensive overview on the latest advances, this volume of Frontiers in Diabetes will be of particular interest to all healthcare providers involved in the daily management of patients with diabetes or related diseases.
Intended for diabetes researchers and medical professionals who work closely with patients with diabetes, this newly updated and expanded edition provides new perspectives and direct insight into the causes and consequences of this serious medical condition from one of the foremost experts in the field. Using the latest scientific and medical developments and trends, readers will learn how to identify, prevent, and treat this challenging phenomenon within the parameters of the diabetes care regimen.
Diabetes and hypertension have evolved as two of the modern day epidemics affecting millions of people around the world. These two common co-morbidities lead to substantial increase in cardiovascular disease, the major cause of morbidity and mortality of adults around the world. In Diabetes and Hypertension: Evaluation and Management, a panel of renowned experts address a range of critical topics -- from basic concepts in evaluation and management of diabetes and hypertension, such as dietary interventions, to evaluation and management of secondary hypertension in clinical practice. Other chapters focus on high cardiovascular risk populations such as those with coronary heart disease, chronic kidney disease and minority patients. In addition, evolving concepts and new developments in the field are presented in other chapters, such as prevention of type 2 diabetes and the epidemic of sleep apnea and its implication for diabetes and hypertension evaluation and management. An important title covering two of the most troubling disorders of our time, Diabetes and Hypertension: Evaluation and Management will provide the busy practitioner with cutting edge knowledge in the field as well as practical information that can translate into better care provided to the high-risk population of diabetics and hypertensive patients.
The American Diabetes Association/JDRF Type 1 Diabetes Sourcebook serves as both an evidence-based reference work and consensus report outlining the most critical components of care for individuals with type 1 diabetes throughout their lifespan. The volume serves not only as a comprehensive guide for clinicians, but also reviews the evidence supporting these components of care and provides a perspective on the critical areas of research that are needed to improve our understanding of type 1 diabetes diagnosis and treatment. The volume focuses specifically on the needs of patients with type 1 diabetes and provides clear and detailed guidance on the current standards for the optimal treatment of type 1 diabetes from early childhood to later life. To accomplish the book’s editorial goals, Editors-in-Chief, Drs. Anne Peters and Lori Laffel, assembled an editorial steering committee of prominent research physicians, clinicians, and educators to develop the topical coverage. In addition, a Managing Editor was brought on to help the authors write and focus their chapters.
Stem Cell Therapy for Diabetes, one of the latest installments of the Stem Cell Biology and Regenerative Medicine series, reviews the three main approaches for generation of sufficient numbers of insulin-producing cells for restoration of an adequate beta-cell mass: beta-cell expansion, stem-cell differentiation, and nuclear reprogramming. Adeptly collecting the research of the leading scientists in the field, Stem Cell Therapy for Diabetes compares the merits of employing autologous versus banked allogeneic cell sources for generation of surrogate beta cells, and addresses tissue engineering and ways for cell protection from recurring autoimmunity and graft rejection. Stem Cell Therapy for Diabetes provides essential reading for those especially interested in tracking the progress in applying of one of the most exciting new developments in bio-medicine towards a cure for diabetes.
Over 20 million people in the United States have diabetes, a metabolic disorder characterized by the body's lack of production or ineffective use of insulin, and the rate is on the rise. Diabetes can cause acute, as well as long-term complications when not properly controlled. Some of the complications may include coma, cardiovascular disease, renal failure, blindness, nerve damage, vascular damage, and poor healing which can lead to amputation. Though there is no cure for either Type I or Type II diabetes, ongoing effort to develop new drug and gene therapies continues. In the meantime, the goals of treatment are disease management, prevention of complications, and improved quality of life. The choice of therapeutics varies by diabetes type and may depend on other significant factors. The selected regimen often includes medication, injection therapy, exercise and change in diet. Over the past few decades, awareness of the importance of early diagnosis and treatment of diabetes has increased significantly. With approximately one-third of those affected by diabetes unaware of their illness, it is critical to make every effort to identify the disease early in its course. The primary care physician is frequently the first to see patients presenting with pre-diabetes and diabetes symptoms. This highly practical volume is specifically designed for primary care physicians and internists on the frontlines of care. It provides a clinically-focused roadmap to providing optimal care for patients with pre-diabetes and diabetes, from the initial patient visit through testing, goal-setting and follow-up care. It offers up-to-date information on diagnosis and treatment options for all types of diabetes, helping to expedite delivery of appropriate care. Part of the new Oxford American Endocrinology Library, this concise yet comprehensive guide covers current approaches and new developments in the diagnosis, management and treatment of diabetes, including Type I, Type II, and gestational diabetes, as well as additional notes on pre-diabetes. The text covers new and emerging pharmacotherapies and complementary treatment guidelines, as well as valuable guidance on managing the major complications of diabetes. In addition to diet and exercise tips for patients, the guide also provides strategies and tools for inspiring healthier lifestyles and patient compliance to reach health goals.
Diabetes continues to spread worldwide. Traditionally diabetes in adults has not been considered a serious life-threatening disease. This attitude needs to be changed, however, since the complications associated with the adult form of diabetes affect almost every organ system. The high morbidity and mortality of Non-Insulin-Dependent Diabetes Mellitus (NIDDM) suggest that current treatment strategies are unsatisfactory, pointing to an urgent need for new therapeutic approaches. This volume provides a comprehensive description and evaluation of recently obtained and previously unpublished data written by leading experts in the field, together with a discussion of antidiabetics under development and new approaches for the management of type 2 diabetes.